Jounce Therapeutics Profile

14.6
USD 0.18  1.22%
14.6Last Month High 17.82 
14.05Trading Day  High 14.84 

Jounce Therapeutics Summary

Jounce Therapeutics Inc (JNCE) is traded on BATS Exchange in USA. It is located in MASSACHUSETTS, U.S.A and employs 8 people. Jounce Therapeutics is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Small-Cap' category with current market capitalization of 495.47 M. Jounce Therapeutics Inc has 32.19 M outstanding shares of which 2.01 M shares are currently shorted by private and institutional investors with about 17.39 trading days to cover. The company currently holds about 270.8 M in cash with 160.96 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.42.
Check Jounce Therapeutics Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Acadian Asset Management LlcCommon Shares317.2 K4.9 M
Conning IncCommon Shares126 K2 M
View Jounce Therapeutics Diagnostics

Selected Jounce Therapeutics Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Jounce Therapeutics Against Markets

Current Ratings  

Jounce Therapeutics 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
< 52% 
Jounce Therapeutics is entity of United States. It is traded as Stock on NASDAQ exchange. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameJounce Therapeutics Inc
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
RegionNorth America
ExchangeBATS Exchange
CIK Number01640455.0
CUSIP481116101
IndustryPharmaceutical Products
BenchmarkDOW
CurrencyUSD - US Dollar

Recommendations

Jounce Therapeutics Analyst Recommendations
Target PriceAdvice# of Analysts
30.0Strong Buy3Odds
Jounce Therapeutics Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Jounce Therapeutics Analyst Advice  

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Earnings

Jounce Therapeutics Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.25November 8, 2017
Jounce Therapeutics Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate